| 2,339 | 44 | 63 |
| 下载次数 | 被引频次 | 阅读次数 |
糖类化合物(单糖、寡糖和多糖)是自然界生物体内存在最广泛的物质之一,与核酸、蛋白质、脂质等构成生命活动的基本物质。多糖类成分是中药中重要的有效物质,已在免疫调节、抗病毒、抗肿瘤、抗辐射、抗衰老和降血脂等方面展示出显著的药理活性。近年来,中药多糖降血脂作用的研究引起国内外学者高度关注并取得重要进展。本文综述了近年来国内外对中药多糖降血脂作用机制的研究进展,并对中药多糖应用于高血脂治疗的前景进行了展望,以期为进一步开发以中药多糖为来源的中药新药提供参考。
Abstract：Carbohydrates(monosaccharide, oligosaccharide and polysaccharide) are one of the most widely existed substances in organisms in nature, which constitute the basic substances of the life activities with nucleic acids, proteins, and lipids. Polysaccharides are important effective substances in traditional Chinese medicine, which have shown remarkable pharmacological activities, including immune regulation, antiviral, anti-tumor, anti-radiation, anti-aging and lipid lowering effect. In recent years, the lipid-lowering effect of polysaccharides from traditional Chinese medicine has attracted a great attention and interest of domestic and foreign scholars and some important progress has been made. This paper reviewed the research progress on the lipid-lowering effect of polysaccharides from traditional Chinese medicine and its mechanism in recent years, so as to provide reference for the further development of new drugs from traditional Chinese medicine polysaccharides.
[1]Demyen M,Alkhallouf K,Pyrsopoulos N T.Lipid-lowering agents and hepatotoxicity[J].Clinics in Liver Disease,2013,17(4):699-714.
[2]Essers Dirk,Schaublin Martina,Kullak-Ublick Gerd A.Statin-associated immune-mediated necrotizing myopathy:a retrospective analysis of individual case safety reports from VigiBase[J].European Journal of Clinical Pharmacology,2019,75(3):409-416.
[3]李娜，余璇，于巧红，等.中药多糖类成分稳定性研究进展[J].中国中药杂志，2019,44(22):4793-4799.
[4]吴雅清，许瑞安.降血脂多糖的研究进展[J].中国中药杂志，2018,43(17):3451-3459.
[5]杨夏，冯颖淑，童珊珊，等.降血脂多糖活性机制及构效关系研究进展[J].中国中药杂志，2018,43(20):4011-4018.
[6]刘姚，陈婷婷，傅凌韵，等.青钱柳多糖对高脂血症小鼠脂肪酸合成酶(FAS)表达影响[J].江西农业大学学报，2013,35(2):392-397.
[7]郭守东，崔英杰，王仁重，等.蛹虫草多糖的分离纯化及促胆固醇逆向转运研究[J].中国中药杂志，2014,39(17):3316-3320.
[8]王凯，李敏，张言捷，等.孔石莼多糖及其磺化衍生物HU体外结合脂类和胆固醇的研究[J].药学研究，2013,32(7):379-383.
[9]曾桥，韦承伯，缑会莉，等.杜仲叶茯砖茶多糖提取工艺优化及抗氧化降血脂活性[J].食品科技，2018,43(8):184-192.
[10]朱晓丹，李光华，周旭，等.枸杞多糖对高脂血症小鼠血脂及肝脏氧化应激的影响[J].宁夏医科大学学报，2016,38(4):357-360.
[11]孔瑕，刘娇娇，李慧，等.黄精多糖对高脂血症小鼠脂代谢相关基因mRNA及蛋白表达的影响[J].中国中药杂志，2018,43(18):3740-3747.
[12]钱增堃，崔凡，凌云熹，等.泽泻多糖对糖尿病大鼠肝脏糖脂代谢的影响[J].中国实验方剂学杂志，2018,24(11):117-125.
[13]Miao J,Haas J.T.,Manthena P,et al.Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins[J].Journal of Lipid Research,2014,55(4):659-667.
[14]Wang Chun-Mei,Yuan Rong-Shuang,Zhuang Wen-Yue,et al.Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice[J].Lipids in Health and Disease,2016,(15):195.
[15]张可锋，高雅，曹后康，等.基于AMPK/SREBP-1通路研究狗肝菜多糖对高脂饮食大鼠糖脂代谢的影响[J].天然产物研究与开发，2019,31(10):1777-1782,1814.
[16]Jia Li,Li Wang.Lycium barbarum polysaccharide attenuates high-fat diet-induced hepatic steatosis by up-regulating SIRT1 expression and deacetylase activity[J].Scientific reports,2016,(6):36209.
[17]程艳芬，韩爱丽，云少君，等.珊瑚状猴头菌多糖降血胆固醇作用及机制[J].营养学报，2018,40(2):172-176.
[18]周芹，段晓云，武林鑫，等.附子多糖对大鼠食诱性高胆固醇血症的预防作用及机制研究[J].中国药理学通报，2011,27(4):492-496.
[19]Yang Shuli,Si Lihui,Fan Limei,et al.Polysaccharide IV from Lycium barbarum L.Improves Lipid Profiles of Gestational Diabetes Mellitus of Pregnancy by Upregulating ABCA1 and Downregulating Sterol Regulatory Element-Binding Transcription 1 via miR-33[J].Frontiers in Endocrinology,2018,(9):49.
[20]王颖，陈思羽，杨泽民.黄芪多糖对高糖高脂饮食模型大鼠肠道甜味受体通路的影响[J].中国实验方剂学杂志，2019,25(10):64-68.
[21]杨波，许智莹，林程程，等.五味子、黄芪混合多糖对大鼠高脂血症的降脂作用[J].食品工业科技，2020,41(16):314-317,325.
[22]马尧，姜维娜，江红.2型糖尿病伴高脂血症患者氧化应激反应与血脂代谢紊乱的关系研究[J].临床和实验医学杂志，2017,16(11):1102-1104.
[23]植飞，邢琪昌，汪莹，等.佛手山药多糖对2型糖尿病大鼠糖脂代谢及氧化应激的影响[J].食品科学，2017,38(5):262-266.
[24]蒋长兴，蒋顶云，熊清平，等.鸡内金多糖对高脂血症大鼠血脂、血液流变学及氧化应激指标的影响[J].中药药理与临床，2012,28(5):75-78.
[25]苑荣爽，李贺，孙靖辉，等.北五味子多糖对高脂诱导非酒精性脂肪性肝病大鼠的降血脂作用及其抗氧化活性[J].吉林大学学报(医学版),2017,43(6):1103-1108,13.
[26]罗朵生，李坤平，朴胜华，等.高脂血症大鼠造模过程中血液代谢组学研究[J].中药新药与临床药理，2016,27(1):70-74.
[27]孟祥云，郭树明，杨丽霞.中药植物多糖对2型糖尿病胰岛素抵抗的作用机制研究进展[J].中国实验方剂学杂志，2017,23(8):220-225.
[28]宗灿华，田丽梅.枸杞多糖对2型糖尿病大鼠胰岛素抵抗及脂联素基因表达的影响[J].中国康复理论与实践，2008,(6):531-532.
[29]Cheng Zhen-yong,Hu Min,Tao Jun,et al.The protective effects of Chinese yam polysaccharide against obesity-induced insulin resistance[J].Journal of Functional Foods,2019,(55):238-247.
[30]郑园园，王健，蒋剑平，等.玄参多糖对2型糖尿病大鼠糖脂代谢及肝胰岛素信号通路的影响[J].中草药，2020,51(6):1586-1592.
[31]Li Xin,Zeng Feng,Huang Yi-fan,et al.The Positive Effects of Grifola frondosa Hetero-polysaccharide on NAFLD and Regulation of the Gut Microbiota[J].International journal of molecular sciences,2019,20(21):5302.
[32]周欣，付志飞，谢燕，等.中药多糖对肠道菌群作用的研究进展[J].中成药，2019,41(3):623-627.
[33]梁源，于瑞丽，尹悦，等.肠道菌群及其代谢产物在糖脂代谢中的作用[J].生理科学进展，2019,50(5):321-325.
[34]Xiong Qing-ping,Zhu Li-jun,Zhang Feng-min,et al.Protective activities of polysaccharides from Cipangopaludina chinensis against high-fat-diet-induced atherosclerosis via regulating gut microbiota in ApoE-deficient mice[J].Food and Function,2019,10(10):6644-6654.
[35]Shi Lin-lin,Li Yuan,WangYuan,et al.MDG-1,an Ophiopogon polysaccharide,regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice[J].International Journal of Biological Macromolecules,2015,(81):576-583.
基本信息:
DOI：10.13412/j.cnki.zyyl.20210305.002
中图分类号:R285
引用信息:
[1]代云云,谢晓蓉,王鹏波,等.中药多糖降脂作用机理的研究进展[J].中药药理与临床,2021,37(05):219-223.DOI:10.13412/j.cnki.zyyl.20210305.002.
基金信息:
甘肃省重大研发项目(编号：18YF1NA085); 甘肃省教育厅成果转化项目(编号：2017D-16); 宁夏回族自治区重点研发计划重大重点项目(编号：2019BEF02006)
2021-03-08
2021-03-08
2021-03-08